Cargando…

Obesity diminishes response to PD-1-based immunotherapies in renal cancer

BACKGROUND: Obesity is a major risk factor for renal cancer, yet our understanding of its effects on antitumor immunity and immunotherapy outcomes remains incomplete. Deciphering these associations is critical, given the growing clinical use of immune checkpoint inhibitors for metastatic disease and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boi, Shannon K, Orlandella, Rachael M, Gibson, Justin Tyler, Turbitt, William James, Wald, Gal, Thomas, Lewis, Buchta Rosean, Claire, Norris, Katlyn E, Bing, Megan, Bertrand, Laura, Gross, Brett P, Makkouk, Amani, Starenki, Dmytro, Farag, Kristine I, Sorge, Robert E, Brown, James A, Gordetsky, Jennifer, Yasin, Hesham, Garje, Rohan, Nandagopal, Lakshminarayanan, Weiner, George J, Lubaroff, David M, Arend, Rebecca C, Li, Peng, Zakharia, Yousef, Yang, Eddy, Salem, Aliasger K, Nepple, Kenneth, Marquez-Lago, Tatiana T, Norian, Lyse A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757487/ https://www.ncbi.nlm.nih.gov/pubmed/33427691 http://dx.doi.org/10.1136/jitc-2020-000725

Ejemplares similares

Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma
por: Gibson, Justin T., et al.
Publicado: (2020)

Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
por: Turbitt, William J., et al.
Publicado: (2021)

Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
por: Gibson, Justin T., et al.
Publicado: (2020)

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?
por: Farag, Kristine I., et al.
Publicado: (2021)

The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
por: Orlandella, Rachael M., et al.
Publicado: (2020)

Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2
por: Hale, Malika, et al.
Publicado: (2015)

Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects
por: Buchta, Claire M., et al.
Publicado: (2017)

Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics
por: Turbitt, William J., et al.
Publicado: (2019)

Checkpoint inhibitors in ovarian cancer: A review of preclinical data
por: Doo, David W., et al.
Publicado: (2019)

Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
por: Norian, Lyse A., et al.
Publicado: (2011)

A Review of the Role of Wnt in Cancer Immunomodulation
por: Goldsberry, Whitney N., et al.
Publicado: (2019)

Rapid Maturation of Effector T Cells in Tumors, but Not Lymphoid Organs, during Tumor Regression
por: Norian, Lyse A., et al.
Publicado: (2007)

PARP Inhibitors in Prostate and Urothelial Cancers
por: Garje, Rohan, et al.
Publicado: (2020)

Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy
por: Norian, Lyse A., et al.
Publicado: (2012)

Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8(+) T cells in the mouse
por: Lemke, Caitlin D., et al.
Publicado: (2011)

The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
por: Geary, Sean M., et al.
Publicado: (2013)

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
por: Borcherding, Nicholas, et al.
Publicado: (2021)

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
por: Garje, Rohan, et al.
Publicado: (2020)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

Role of NK Cell Subsets in Organ-Specific Murine Melanoma Metastasis
por: Ballas, Zuhair K., et al.
Publicado: (2013)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Synergistic Induction of Apoptosis in Primary B-CLL Cells after Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Histone Deacetylase Inhibitors
por: Norian, Lyse A., et al.
Publicado: (2009)

Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer
por: Demark-Wahnefried, Wendy, et al.
Publicado: (2017)

Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy
por: Venur, Vyshak Alva, et al.
Publicado: (2017)

Understanding the Redox Biology of Selenium in the Search of Targeted Cancer Therapies
por: Stolwijk, Jeffrey M., et al.
Publicado: (2020)

Potential Role of Selenium in the Treatment of Cancer and Viral Infections
por: Rataan, Aseel O., et al.
Publicado: (2022)

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment
por: Garje, Rohan, et al.
Publicado: (2018)

LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition
por: Buchta Rosean, Claire, et al.
Publicado: (2023)

CELLULAR REQUIREMENTS FOR THE REJECTION OF SKIN ALLOGRAFTS IN RATS
por: Lubaroff, David M.
Publicado: (1973)

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020)

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies
por: Swami, Umang, et al.
Publicado: (2020)

An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis
por: Kang, Silvia S, et al.
Publicado: (2008)

BKCa channel inhibitor modulates the tumorigenic ability of hormone-independent breast cancer cells via the Wnt pathway
por: SCHICKLING, BRANDON M., et al.
Publicado: (2015)

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth
por: Turner, Taylor B, et al.
Publicado: (2017)

Reply to “Phase II prospective randomized trial of weight loss prior to radical prostatectomy”
por: Demark-Wahnefried, W., et al.
Publicado: (2018)

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
por: Swearson, Samuel, et al.
Publicado: (2022)

BONE MARROW AS SOURCE OF CELLS IN REACTIONS OF CELLULAR HYPERSENSITIVITY : II. IDENTIFICATION OF ALLOGENEIC OR HYBRID CELLS BY IMMUNOFLUORESCENCE IN PASSIVELY TRANSFERRED TUBERCULIN REACTIONS
por: Lubaroff, David M., et al.
Publicado: (1968)

BONE MARROW AS SOURCE OF CELLS IN REACTIONS OF CELLULAR HYPERSENSITIVITY : I. PASSIVE TRANSFER OF TUBERCULIN SENSITIVITY IN SYNGENEIC SYSTEMS
por: Lubaroff, David M., et al.
Publicado: (1968)

Cannot write session to /tmp/vufind_sessions/sess_6bioeo9behnc5657defaijp44g